Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Condition:   Epidermolysis Bullosa Interventions:   Drug: allo-APZ2-OTS;   Drug: Placebo Sponsor:   RHEACELL GmbH & Co. KG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials